Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors

NCT00005952 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Brain and Central Nervous System Tumors
Childhood Germ Cell Tumor
Head and Neck Cancer
Kidney Cancer
Neuroblastoma
Ovarian Cancer
Sarcoma
Testicular Germ Cell Tumor

Interventions

BIOLOGICAL: filgrastim
DRUG: temozolomide
PROCEDURE: peripheral blood stem cell transplantation

Sponsor

Duke University

Collaborators

[object Object]